Twist Bioscience presented figures for the most recent quarter, which ended on September 30, 2023, on November 17, 2023.
Earnings per share were negative. The loss per paper was put at USD 0.810. In the same quarter last year, the books had -0.910 USD per share.
Sales were reported at USD 67.0 million, compared to the same quarter last year when sales were USD 57.3 million.
For the fiscal year, a loss per share of $3,600 was announced, compared to -$4,040 the previous year.
On the sales side, there was an increase of 20.41 percent compared to sales in the previous year. Sales were recently reported at USD 245.11 million. The previous year there were $203.57 million on the books.
For the past fiscal year, analysts’ estimates were a loss of $3.718 per share and sales of $241.58 million.
Editorial team finanzen.net
Selected leverage products on Twist Bioscience
With knock-outs, speculative investors can participate disproportionately in price movements. Simply select the lever you want and we will show you suitable open-end products on Twist Bioscience
The leverage must be between 2 and 20
Advertising